Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Torrent Completes Acquisition of Zyg Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Torrent Completes Acquisition of Zyg Pharma

Strengthens position in niche dermatological segments

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Torrent Pharmaceuticals Limited has completed the 100% acquisition of Zyg Pharma Private Limited, a company engaged in manufacturing various dermatological formulations like creams, ointments, gels and lotions.

Zyg Pharma is part of the Encore Group, promoted by the Merchant family and has been involved in the specialty pharmaceutical business for over 50 years. The manufacturing facility is located at Pithampur, Indore, India and is approved by various regulatory authorities including the U.S. FDA and TGA Australia. The company has capabilities for on site development, analytical methods development and QC laboratory with separate areas for chemical, instrumental and micro sections.

In line with its strategy to diversify into new therapy segments, the acquisition will help Torrent to strengthen its position in niche dermatological segments especially in the developed markets of the U.S. and Europe. The company has been a manufacturing partner to several international companies in India and it has also built a successful international business through partners in regulated markets as well as in emerging markets.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics